Evaluation of Trastuzumab Without Chemotherapy as a Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients - Related Studies

Evaluation of Trastuzumab Without Chemotherapy as a Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients (RESPECT)

This study is currently recruiting participants.

Verified June 2011 by Comprehensive Support Project for Oncology Research

Study NCT01104935 Information provided by Comprehensive Support Project for Oncology Research

First Received on November 6, 2009. Last Updated on April 17, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Cancer

Additional conditions recognized in this trial

Breast Neoplasms

More general conditions related to this trial

Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

Interventions listed in this trial

trastuzumab
chemotherapy

More general drug interventions related to this trial

Sponsors listed in this trial